ArticleScientific reports2025
An MRI-based deep transfer learning radiomics nomogram for predicting meningioma grade.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Central Nervous System Involvement in Acute Myeloid Leukemia: From Pathophysiology to Neuroradiologic Features and the Emerging Role of Artificial Intelligence.Journal of clinical medicine · 2026Review
- Advancements in the application of MRI radiomics in meningioma.Radiation oncology (London, England) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to establish a nomogram based on clinical, radiomics, and deep transfer learning (DTL) features to predict meningioma grade. Three hundred forty meningiomas from one hospital composed the training set, and 102 meningiomas from another hospital composed the test set. The enhanced T1 WI images were used for analysis. The clinical, radiomics and DTL features were selected to construct the model. Radiomics and DTL scores were calculated. The deep transfer learning radiomics (DTLR) nomogram was developed on the basis of selected clinical features, radiomics scores and DTL scores. Receiver operating characteristic (ROC) curves and decision curve analysis (DCA) curves were drawn. The clinical features of sex, shape, indistinct margin and peritumoral edema were selected and used to construct the clinical model. Thirty-two radiomics features and 28 DTL features were selected for model construction. The clinical model had an AUC of 0.788. (95% CI: 0.6996-0.8756), with an accuracy of 0.745, a sensitivity of 0.941, and a specificity of 0.549 in the test set. The DTLR nomogram had the highest AUC of 0.866 (95% CI: 0.7984-0.9340), with an accuracy of 0.804, a sensitivity of 0.745, and a specificity of 0.863 in the test set. Compared with the other models, the DTLR nomogram had the greatest net benefit according to the DCA. There was a significant difference between the DTLR nomogram and the clinical model, no significant difference between the rest models in DeLong test.The DTLR nomogram has superior predictive value in DCA and could be a valuable method in clinical decision-making. Given the results of DeLong test, only the radiomics model is sufficient and there is no need to add DTL features. As a new attempt, the DTLR nomogram needs to be improved in the future study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.